ScripFive Prime Therapeutics Inc. , a company focused on immuno-oncology therapeutics, has appointed its chief operating officer (COO) Aron Knickerbocker as CEO and president – effective Jan. 1, 2017.
In VivoNew At The Helm Company Changes ANDRE , Patrick, PhD To: Pliant Therapeutics Inc. , VP, Biology (April) From: Merck Sharp & Dohme Corp., Principal Scientist Phone: 650-481-6708 BRENNEMAN , Rya
In VivoNew At The Helm Company Changes ALLSOP , David To: Amicus Therapeutics Inc. , SVP, International (April) From: Biogen Idec, SVP, Europe & Canada Phone: 609-662-2000 ATHA , Cindy To: Atossa
ScripStart-Up Execs Cristal Therapeutics Jeroen Tonnaer, PhD To: CBO (April) From: Merck & Co. Inc. Phone: +31 433 88 58 68 Editas Medicine Inc. Vic Myer, PhD To: CTO (April) From: Exec. Dir.